OrganOx 's metra normothermic machine perfusion platform gained approval in Australia, Europe, Canada, and the US.

A PE-backed medical technology company in Oxford specialising in organ preservation has completed a $142m primary and ...

The strange world of organ preservation is spawning new tech firms. OrganOx has added impetus to the industry with a $142mn ...

OrganOx announced today that it completed a $142 million primary and secondary equity financing to accelerate growth ...

OrganOx, with its system for actively preserving viable donor tissue ahead of a transplant procedure, has raised $142 million ...

OXFORD, United Kingdom and MADISON, N.J., Feb. 24, 2025 (GLOBE NEWSWIRE) -- OrganOx Ltd., a leading organ medical technology company, successfully completed a $142 million primary and secondary ...

Stuge, MD, MBA, and Executive Chairman at OrganOx. “We’re thrilled to back OrganOx as they advance a technology platform that successfully addresses the quadruple aim of healthcare, benefitting ...

Organox Ltd. raised $142 million in financing to accelerate the growth of its Metra platform that preserves and transport livers for transplantation. The funds will allow the company to strengthen its ...

OrganOx, a British developer of technologies to maintain organs for transplant, raised $142m in primary and secondary funding ...

OXFORD, United Kingdom and MADISON, N.J., Feb. 24, 2025 (GLOBE NEWSWIRE) -- OrganOx Ltd., a leading organ medical technology company, successfully completed a $142 million primary and secondary equity ...